advertisement

---

Odani-Kawabata N 12

Showing records 1 to 12 | Display all abstracts from Odani-Kawabata N

117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Bacharach J
American Journal of Ophthalmology 2024; 263: 23-34

---

117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Wang TH
Clinical Ophthalmology 2024; 18: 2093-2106

---

117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Brubaker JW
American Journal of Ophthalmology 2024; 263: 23-34

---

117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Aung T; Lu DW
Clinical Ophthalmology 2024; 18: 2093-2106

---

117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Evans DG; Lu F
American Journal of Ophthalmology 2024; 263: 23-34

---

117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
George R
Clinical Ophthalmology 2024; 18: 2093-2106

---

117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Odani-Kawabata N
American Journal of Ophthalmology 2024; 263: 23-34

---

117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Senthil S
Clinical Ophthalmology 2024; 18: 2093-2106

---

117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Yamabe T
American Journal of Ophthalmology 2024; 263: 23-34

---

117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Lu F
Clinical Ophthalmology 2024; 18: 2093-2106

---

117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Wirta DL
American Journal of Ophthalmology 2024; 263: 23-34

---

117535 Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial
Odani-Kawabata N; Park KH
Clinical Ophthalmology 2024; 18: 2093-2106

---